Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Diabetes Control and Complications Trial (DCCT) demonstrated the powerful impact of glycemic control on the early manifestations of microvascular complications. Contemporary prospective data on the evolution of macrovascular and late microvascular complications of type 1 diabetes are limited. The Epidemiology of Diabetes Interventions and Complications (EDIC) study is a multicenter, longitudinal, observational study designed to use the well-characterized DCCT cohort of > 1,400 patients to determine the long-term effects of prior separation of glycemic levels on micro- and macrovascular outcomes. RESEARCH DESIGN AND METHODS: Using a standardized annual history and physical examination, 28 EDIC clinical centers that were DCCT clinics will follow the EDIC cohort for 10 years. Annual evaluation also includes resting electrocardiogram. Doppler ultrasound measurements of ankle/arm blood pressure, and screening for nephropathy. At regular intervals, a timed 4-h urine is collected, lipid profiles are obtained, and stereoscopic fundus photographs are taken. In addition, dual B-mode Doppler ultrasound scans of the common and internal carotid arteries will be performed at years 1 and 6 and at study end. RESULTS: Written informed consent was obtained from 96% of the DCCT subjects. The participants, compared with nonparticipants, tended to have better glycemic control at the completion of the DCCT and were more likely to have their diabetes care provided by DCCT personnel. The EDIC baseline measurement stratified by sex delineates multiple cardiovascular disease risk factor differences such as age (older in men), waist-to-hip ratio (higher in men). HDL cholesterol (lower in men), hypertension (more prevalent in men), and maximum intimal-medial thickness of common and internal carotid arteries (thicker in men). Of the original conventional treatment group, 69% have changed to continuous subcutaneous insulin infusion or multiple daily injections. Although the mean HbA1c difference between the intensive and conventional treatment groups narrowed at EDIC years 1 and 2, HbA1c remained significantly lower in the intensive group. Of all expected clinic visits, 95% were completed, and the quality of EDIC data is very similar to that observed in the DCCT. CONCLUSIONS: Although obvious problems exist in extended follow-up studies of completed clinical trials, these are balanced by the value of continued systematic observation of the DCCT cohort. In contrast to other epidemiologic studies, EDIC will provide 1) definitive data on type 1 as distinct from type 2 diabetes; 2) reliance on prospective rather than on cross-sectional analysis; 3) long-term follow-up in a large population; 4) consistent use of objective, reliable measures of outcomes and glycemia; and 5) observation of patients from before the onset of complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Mc Causland, F. R., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,690
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,828
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Cited by
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
“Within a year, the observational phase of the DCCT/Epidemiology of Diabetes Interventions and Complications (EDIC) study commenced.(19) A total of 1375 of the DCCT subjects (95%) (half from each treatment group) volunteered to participate in EDIC.”
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Diabetic Retinopathy Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.025 · Cited by 717
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Long-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII
Klein, R., Knudtson, M. D., Lee, K. E., Gangnon, R., & Klein, B. E. K. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.023 · Cited by 584
Increased mortality of patients with diabetes reporting severe hypoglycemia
McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2012) · Diabetes Care · doi:10.2337/dc11-2054 · Cited by 539
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 433
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Albers, J. W., Herman, W. H., Pop-Busui, R., Feldman, E. L., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & for the DCCT/EDIC Research Group (2010) · Diabetes Care · doi:10.2337/dc09-1941 · Cited by 401
High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
Soedamah-Muthu, S. S., Fuller, J. H., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1433 · Cited by 395
In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease
Cruzat, A., Qazi, Y., & Hamrah, P. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2016.09.004 · Cited by 364
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion
Martin, C. L., Albers, J., Herman, W. H., Cleary, P., Waberski, B., Greene, D. A., Stevens, M. J., & Feldman, E. L. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1549 · Cited by 350
(2001) · PubMed · Cited by 344
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Sima, A. A. F., & Feldman, E. L. (2009) · Diabetes · doi:10.2337/db08-1771 · Cited by 344
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2015) · Diabetes · doi:10.2337/db14-0930 · Cited by 333
Pop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort
Lyons, T. J., Jenkins, A. J., Zheng, D., Lackland, D. T., McGee, D., Garvey, W. T., & Klein, R. L. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0648 · Cited by 309
Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1098 · Cited by 306
Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials
Ang, L., Jaiswal, M., Martin, C., & Pop-Busui, R. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0528-7 · Cited by 303
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
Skyler, J. S., Cefalu, W. T., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., & Gelfand, R. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03638-2 · Cited by 301
Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes
Pezzolesi, M. G., Poznik, G. D., Mychaleckyj, J. C., Paterson, A. D., Barati, M. T., Klein, J. B., Ng, D. P. K., Placha, G., Canani, L. H., Bochenski, J., et al. (2009) · Diabetes · doi:10.2337/db08-1514 · Cited by 291
Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control
Edelman, S. V., & Polonsky, W. H. (2017) · Diabetes Care · doi:10.2337/dc16-1974 · Cited by 285
Perspectives on diabetic retinopathy
Aiello, L. M. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00219-8 · Cited by 282
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring
Kovatchev, B. P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.3 · Cited by 272
Nathan, D. M., Bayless, M., Cleary, P., Genuth, S., Gubitosi-Klug, R., Lachin, J. M., Lorenzi, G., Zinman, B., & for the DCCT/EDIC Research Group (2013) · Diabetes · doi:10.2337/db13-1093 · Cited by 272
Cleary, P. A., Orchard, T. J., Genuth, S., Wong, N. D., Detrano, R., Backlund, J.-Y. C., Zinman, B., Jacobson, A., Sun, W., Lachin, J. M., et al. (2006) · Diabetes · doi:10.2337/db06-0653 · Cited by 264
Syed, F. Z. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202203150 · Cited by 255
Fear of hypoglycaemia in parents of young children with type 1 diabetes: A systematic review
Barnard, K., Thomas, S., Royle, P., Noyes, K., & Waugh, N. (2010) · BMC Pediatrics · doi:10.1186/1471-2431-10-50 · Cited by 239
Heald, A. H., Stedman, M., Davies, M., Livingston, M., Alshames, R., Lunt, M., Rayman, G., & Gadsby, R. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000210 · Cited by 237
White, N. H., Sun, W., Cleary, P. A., Tamborlane, W. V., Danis, R. P., Hainsworth, D. P., Davis, M. D., & for the DCCT-EDIC Research Group (2010) · Diabetes · doi:10.2337/db09-1216 · Cited by 235
Braffett, B. H., Gubitosi-Klug, R. A., Albers, J. W., Feldman, E. L., Martin, C. L., White, N. H., Orchard, T. J., Lopes-Virella, M., Lachin, J. M., Pop-Busui, R., et al. (2020) · Diabetes · doi:10.2337/db19-1046 · Cited by 221
Sex differences in micro- and macro-vascular complications of diabetes mellitus
Maric-Bilkan, C. (2017) · Clinical Science · doi:10.1042/cs20160998 · Cited by 217
Thyroid Dysfunction in Patients With Type 1 Diabetes
Umpierrez, G. E., Latif, K. A., Murphy, M. B., Lambeth, H. C., Stentz, F., Bush, A., & Kitabchi, A. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1181 · Cited by 215
Complications of Type 1 Diabetes
Melendez-Ramirez, L. Y., Richards, R. J., & Cefalu, W. T. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.009 · Cited by 213
Risk Factors for Cardiovascular Disease in Type 1 Diabetes
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group (2016) · Diabetes · doi:10.2337/db15-1517 · Cited by 209
Paterson, A. D., Lopes-Virella, M. F., Waggott, D., Boright, A. P., Hosseini, S. M., Carter, R. E., Shen, E., Mirea, L., Bharaj, B., Sun, L., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.192971 · Cited by 205
Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study
Hainsworth, D. P., Bebu, I., Aiello, L. P., Sivitz, W., Gubitosi-Klug, R., Malone, J., White, N. H., Danis, R., Wallia, A., Gao, X., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2308 · Cited by 204
Mortality in type 1 diabetes in the DCCT/EDIC versus the general population
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-2399 · Cited by 194
and the DCCT/EDIC Research Group, Jacobson, A. M., Ryan, C. M., Cleary, P. A., Waberski, B. H., Weinger, K., Musen, G., & Dahms, W. (2011) · Diabetologia · doi:10.1007/s00125-010-1883-9 · Cited by 168
Bharucha, A. E., Batey-Schaefer, B., Cleary, P. A., Murray, J. A., Cowie, C., Lorenzi, G., Driscoll, M., Harth, J., Larkin, M., Christofi, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.007 · Cited by 156
Frequency of evidence-based screening for retinopathy in type 1 diabetes
The DCCT/EDIC Research Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612836 · Cited by 141
Epigenetic Changes in Diabetes and Cardiovascular Risk
Keating, S. T., Plutzky, J., & El-Osta, A. (2016) · Circulation Research · doi:10.1161/circresaha.116.306819 · Cited by 139
Jacobson, A. M., Ryan, C. M., Braffett, B. H., Gubitosi-Klug, R. A., Lorenzi, G. M., Luchsinger, J. A., Trapani, V. R., Bebu, I., Chaytor, N., Hitt, S. M., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00086-3 · Cited by 138
Purnell, J. Q., Braffett, B. H., Zinman, B., Gubitosi-Klug, R. A., Sivitz, W., Bantle, J. P., Ziegler, G., Cleary, P. A., Brunzell, J. D., DCCT/EDIC Research Group, et al. (2017) · Diabetes Care · doi:10.2337/dc16-2523 · Cited by 120
Sousa, G. R., Pober, D., Galderisi, A., Lv, H., Yu, L., Pereira, A. C., Doria, A., Kosiborod, M., & Lipes, M. A. (2019) · Circulation · doi:10.1161/circulationaha.118.036068 · Cited by 117
Pop-Busui, R., Braffett, B. H., Zinman, B., Martin, C., White, N. H., Herman, W. H., Genuth, S., Gubitosi-Klug, R., & the DCCT/EDIC Research Group (2017) · Diabetes Care · doi:10.2337/dc16-1397 · Cited by 116
Association Between Cardiovascular Autonomic Neuropathy and Left Ventricular Dysfunction
Pop-Busui, R., Cleary, P. A., Braffett, B. H., Martin, C. L., Herman, W. H., Low, P. A., Lima, J. A. C., & Bluemke, D. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.028 · Cited by 88
Gubitosi-Klug, R. A., Braffett, B. H., Hitt, S., Arends, V., Uschner, D., Jones, K., Diminick, L., Karger, A. B., Paterson, A. D., Roshandel, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143011 · Cited by 86
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes
Paterson, A. D., Rutledge, B. N., Cleary, P. A., Lachin, J. M., Crow, R. S., & for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2007) · Diabetes Care · doi:10.2337/dc06-1441 · Cited by 81
Lagani, V., Chiarugi, F., Thomson, S., Fursse, J., Lakasing, E., Jones, R. W., & Tsamardinos, I. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.03.001 · Cited by 74
Morello, C. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s26889 · Cited by 71
Garg, S. K., Grunberger, G., Weinstock, R., Lawson, M. L., Hirsch, I. B., DiMeglio, L. A., Pop-Busui, R., Philis-Tsimikas, A., Kipnes, M., Liljenquist, D. R., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0421 · Cited by 63
Bebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M., Lachin, J. M., & the DCCT/EDIC Research Group (2019) · Diabetes Care · doi:10.2337/dc18-1613 · Cited by 62
Marini, S., Trifoglio, E., Barbarini, N., Sambo, F., Di Camillo, B., Malovini, A., Manfrini, M., Cobelli, C., & Bellazzi, R. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.08.021 · Cited by 61
Pop‐Busui, R., Backlund, J. C., Bebu, I., Braffett, B. H., Lorenzi, G., White, N. H., Lachin, J. M., Soliman, E. Z., & DCCT/EDIC Research Group (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13635 · Cited by 52
Ranjan, A., Schmidt, S., Madsbad, S., Holst, J. J., & Nørgaard, K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12627 · Cited by 39
Gubitosi-Klug, R. A., Braffett, B. H., Bebu, I., Johnson, M. L., Farrell, K., Kenny, D., Trapani, V. R., Meadema-Mayer, L., Soliman, E. Z., Pop-Busui, R., et al. (2022) · Diabetes Care · doi:10.2337/dc21-0629 · Cited by 31
Bebu, I., Braffett, B. H., Schade, D., Sivitz, W., Malone, J. I., Pop-Busui, R., Lorenzi, G. M., Lee, P., Trapani, V. R., Wallia, A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0226 · Cited by 29
Maanaoui, M., Lenain, R., Foucher, Y., Buron, F., Blancho, G., Antoine, C., Caillard, S., Kessler, L., Le Quintrec, M., Villard, O., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00241-9 · Cited by 23
Nathan, D. M., Krause-Steinrauf, H., Braffett, B. H., Arends, V. L., Younes, N., McGee, P., Lund, C., Johnson, M., Lorenzi, G., Gao, X., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0257154 · Cited by 21
Harris, S., Cimino, S., Nguyen, Y., Szafranski, K., & Poon, Y. (2025) · Diabetes Therapy · doi:10.1007/s13300-024-01677-5 · Cited by 12
Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02856-9 · Cited by 5
Metadata
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1999-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 99-111
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2734011609
- Cited by
- 660
- References
- 44
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.